Wound dressing with an air permeable layer

US10426670B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10426670-B2
Application numberUS-201214342466-A
CountryUS
Kind codeB2
Filing dateAug 31, 2012
Priority dateSep 2, 2011
Publication dateOct 1, 2019
Grant dateOct 1, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention relates to a wound dressing which is particularly suited for therapeutically dressing wounds. Said wound dressing comprises at least one air permeable layer having a porous and/or foam-based structure, particularly in the form of a solid foam (“foam layer”), and at least one sorbent in the form of activated carbon.

First claim

Opening claim text (preview).

The invention claimed is: 1. A wound dressing for therapeutic wound care, wherein the wound dressing has a multilayer structure, wherein the multilayer structure comprises at least one air permeable layer with a porous or foam-based structure and at least one layer comprising activated carbon, wherein the air permeable layer without cavities or intervening spaces forms an outer layer of the wound dressing and wherein the wound dressing is adapted to be applied to a wound with the air permeable layer arranged on a side of the wound dressing facing the wound, wherein the air permeable layer is formed by a hydrocolloid foam wherein the hydrocolloid is collagen, wherein the air permeable layer has a compressive hardness in the range from 5 to 50 kPa, wherein the activated carbon comprises granular activated carbon, wherein the wound dressing as a whole is made air permeable with an air permeability of at least 25 l·m −2 ·sec −1 and up to 10,000 l·m −2 ·sec −1 at a flow resistance of 127 Pa, and wherein the air permeable layer has a thickness in the range of from 0.01 to 100 mm and makes up 5% to 95% of the total thickness of the wound dressing. 2. A wound dressing for therapeutic wound care, wherein the wound dressing has a multilayer structure, wherein the multilayer structure comprises at least one air permeable layer with a porous or foam-based structure and at least one layer comprising activated carbon, wherein the air permeable layer forms an outer layer of the wound dressing and wherein the wound dressing is adapted to be applied to a wound with the air permeable layer arranged on a side of the wound dressing facing the wound, wherein the air permeable layer is formed by a hydrocolloid foam wherein the hydrocolloid is collagen, wherein the air permeable layer has a compressive hardness in the range from 5 to 50 kPa, wherein the activated carbon comprises granular activated carbon, and wherein the activated carbon has a micropore volume content formed of micropores with pore diameters of ≤20 Å in the range from 60% to 95%, based on the total pore volume of the activated carbon. 3. A wound dressing for therapeutic wound care, wherein the wound dressing has a multilayer structure, wherein the multilayer structure comprises at least one air permeable layer with a porous or foam-based structure and at least one layer comprising activated carbon, wherein the air permeable layer forms an outer layer of the wound dressing and wherein the wound dressing is adapted to be applied to a wound with the air permeable layer arranged on a side of the wound dressing facing the wound, wherein the air permeable layer is formed by a hydrocolloid foam wherein the hydrocolloid is collagen, wherein the air permeable layer has a compressive hardness in the range from 5 to 50 kPa, wherein the activated carbon comprises granular activated carbon, wherein the activated carbon has a micropore volume content formed of micropores with pore diameters of ≤20 Å in the range from 60% to 95%, based on the total pore volume of the activated carbon, and wherein the activated carbon has a biocidal, biostatic or antimicrobial effect, wherein the biocidal, biostatic or antimicrobial effect of the activated carbon is achieved through the production process of the activated carbon or through treatment of the activated carbon with at least one biocidal, biostatic or antimicrobial active substance.

Assignees

Inventors

Classifications

  • for treating wounds, ulcers, burns, scars, keloids, or the like · CPC title

  • Use of materials characterised by their function or physical properties (liquid bandages A61L26/00) · CPC title

  • Medicaments · CPC title

  • Elemental carbon, e.g. charcoal · CPC title

  • Porous materials, e.g. foams or sponges · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10426670B2 cover?
The invention relates to a wound dressing which is particularly suited for therapeutically dressing wounds. Said wound dressing comprises at least one air permeable layer having a porous and/or foam-based structure, particularly in the form of a solid foam (“foam layer”), and at least one sorbent in the form of activated carbon.
Who is the assignee on this patent?
Bluecher Hasso Von, Schoenfeld Raik, Pallaske Frank, and 1 more
What technology area does this patent fall under?
Primary CPC classification A61L15/325. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Oct 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).